AU2002216107A1 - Substituted pyrrolidines as CCR-3 receptor antagonists - Google Patents
Substituted pyrrolidines as CCR-3 receptor antagonistsInfo
- Publication number
- AU2002216107A1 AU2002216107A1 AU2002216107A AU1610702A AU2002216107A1 AU 2002216107 A1 AU2002216107 A1 AU 2002216107A1 AU 2002216107 A AU2002216107 A AU 2002216107A AU 1610702 A AU1610702 A AU 1610702A AU 2002216107 A1 AU2002216107 A1 AU 2002216107A1
- Authority
- AU
- Australia
- Prior art keywords
- ccr
- receptor antagonists
- substituted pyrrolidines
- pyrrolidines
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25658500P | 2000-12-19 | 2000-12-19 | |
| US60256585 | 2000-12-19 | ||
| PCT/EP2001/014670 WO2002050064A1 (en) | 2000-12-19 | 2001-12-13 | Substituted pyrrolidines as ccr-3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002216107A1 true AU2002216107A1 (en) | 2002-07-01 |
Family
ID=22972794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002216107A Abandoned AU2002216107A1 (en) | 2000-12-19 | 2001-12-13 | Substituted pyrrolidines as CCR-3 receptor antagonists |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6552028B2 (en) |
| EP (1) | EP1358181B1 (en) |
| JP (1) | JP2004519443A (en) |
| KR (1) | KR20030061455A (en) |
| CN (1) | CN1239498C (en) |
| AR (1) | AR035519A1 (en) |
| AT (1) | ATE374198T1 (en) |
| AU (1) | AU2002216107A1 (en) |
| BR (1) | BR0116352A (en) |
| CA (1) | CA2431767A1 (en) |
| DE (1) | DE60130684T2 (en) |
| ES (1) | ES2292530T3 (en) |
| MX (1) | MXPA03005581A (en) |
| WO (1) | WO2002050064A1 (en) |
| ZA (1) | ZA200304530B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004283842A1 (en) * | 2003-10-24 | 2005-05-06 | F. Hoffmann-La Roche Ag | CCR3 receptor antagonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2143143A1 (en) * | 1994-03-08 | 1995-09-09 | Toshihiko Tanaka | 3-phenylpyrrolidine derivatives |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| TR200101397T2 (en) * | 1998-11-20 | 2001-11-21 | F.Hoffmann-La Roche Ag | Piperidine CCR-3 receptor antagonists |
| AU763960B2 (en) | 1998-11-20 | 2003-08-07 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives-CCR-3 receptor antagonists |
| EP1158980B1 (en) | 1998-12-18 | 2005-08-24 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AU2056800A (en) | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | Heterocyclic piperidines as modulators of chemokine receptor activity |
| IL142768A0 (en) | 1998-12-18 | 2002-03-10 | Du Pont Pharm Co | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AU2056700A (en) | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
| EP1140087A4 (en) | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AU2482100A (en) | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| EP1140086A4 (en) | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
-
2001
- 2001-12-13 KR KR10-2003-7008134A patent/KR20030061455A/en not_active Application Discontinuation
- 2001-12-13 AT AT01271370T patent/ATE374198T1/en not_active IP Right Cessation
- 2001-12-13 EP EP01271370A patent/EP1358181B1/en not_active Expired - Lifetime
- 2001-12-13 ES ES01271370T patent/ES2292530T3/en not_active Expired - Lifetime
- 2001-12-13 AU AU2002216107A patent/AU2002216107A1/en not_active Abandoned
- 2001-12-13 CA CA002431767A patent/CA2431767A1/en not_active Abandoned
- 2001-12-13 CN CNB018208789A patent/CN1239498C/en not_active Expired - Fee Related
- 2001-12-13 DE DE60130684T patent/DE60130684T2/en not_active Expired - Fee Related
- 2001-12-13 JP JP2002551560A patent/JP2004519443A/en active Pending
- 2001-12-13 BR BR0116352-3A patent/BR0116352A/en not_active IP Right Cessation
- 2001-12-13 MX MXPA03005581A patent/MXPA03005581A/en active IP Right Grant
- 2001-12-13 WO PCT/EP2001/014670 patent/WO2002050064A1/en active IP Right Grant
- 2001-12-17 AR ARP010105833A patent/AR035519A1/en not_active Application Discontinuation
- 2001-12-19 US US10/034,034 patent/US6552028B2/en not_active Expired - Fee Related
-
2003
- 2003-02-18 US US10/368,097 patent/US20030199532A1/en not_active Abandoned
- 2003-06-10 ZA ZA200304530A patent/ZA200304530B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030061455A (en) | 2003-07-18 |
| US20030199532A1 (en) | 2003-10-23 |
| WO2002050064A1 (en) | 2002-06-27 |
| AR035519A1 (en) | 2004-06-02 |
| CN1481379A (en) | 2004-03-10 |
| ZA200304530B (en) | 2004-09-10 |
| CN1239498C (en) | 2006-02-01 |
| DE60130684T2 (en) | 2008-08-14 |
| JP2004519443A (en) | 2004-07-02 |
| US20020198255A1 (en) | 2002-12-26 |
| EP1358181B1 (en) | 2007-09-26 |
| US6552028B2 (en) | 2003-04-22 |
| ATE374198T1 (en) | 2007-10-15 |
| ES2292530T3 (en) | 2008-03-16 |
| CA2431767A1 (en) | 2002-06-27 |
| EP1358181A1 (en) | 2003-11-05 |
| DE60130684D1 (en) | 2007-11-08 |
| BR0116352A (en) | 2003-12-02 |
| MXPA03005581A (en) | 2003-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001250205A1 (en) | Prostaglandin d2 receptor antagonists | |
| GB2343893B (en) | Pyrrolidine derivative CCR-3 receptor antagonists | |
| AU6690001A (en) | Thrombin receptor antagonists | |
| IL150550A0 (en) | 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists | |
| AU2001269876A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| AU2002235224A1 (en) | Muscarinic antagonists | |
| AU5895500A (en) | Novel indazole peptidomimetics as thrombin receptor antagonists | |
| AU2001264657A1 (en) | Crf receptor antagonists | |
| AU2001273032A1 (en) | Cytokine receptor zcytor17 | |
| AU2441801A (en) | Urotensin-ii receptor antagonists | |
| AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
| AU2001240021A1 (en) | Diazafluorenone il-8 receptor antagonists | |
| AU2001245724A1 (en) | Il-8 receptor antagonists | |
| AU2002216079A1 (en) | Bombesin receptor antagonists | |
| AU2001279950A1 (en) | Tetrahydropyran derivatives as nk-1 receptor antagonists | |
| AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
| AU2001243351A1 (en) | Il-8 receptor antagonists | |
| AU2001295455A1 (en) | Indoline derivatives as 5ht2c antagonists | |
| AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
| AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
| AU2001249573A1 (en) | Chemokine receptor antagonists | |
| AU2001263288A1 (en) | Crf receptor antagonists | |
| AU2002217095A1 (en) | Bombesin receptor antagonists | |
| AU2001241896A1 (en) | Il-8 receptor antagonists | |
| AU2001253172A1 (en) | Il-8 receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |